Cannabis and Tobacco Associated with Brain Volume Reduction
Recent studies on cannabis tobacco brain volume reduction reveal measurable changes in critical brain regions. These findings highlight the importance of clinical awareness when counseling patients. Understanding these effects aids in informed…
Exploring Cannabinoid Ligands in Neurodegenerative Disease Management
Cannabinoid ligands neurodegenerative diseases research highlights their potential in anti-inflammatory and immunomodulatory roles. These ligands may offer disease-modifying perspectives in conditions like Alzheimer's and Parkinson's. Current evidence…
Exploring Neuroprotective Cannabis Clinical Trials and Their Impact
Neuroprotective cannabis clinical trials are advancing research into treatments for neurological disorders. These trials explore cannabis compounds' potential to protect nerve cells. Understanding clinical evidence helps guide safe and effective use.
Radical Revelations: Nitrosative Stress and the Endocannabinoid System in Age-Related Disorders
This endocannabinoid system neurodegeneration research review highlights the critical role of ECS in modulating nitrosative stress pathways. Emerging evidence suggests ECS modulation may influence neuroinflammation and progression of age-related…
Cannabidiol in Developmental Epilepsy: Organoid-Guided Precision Medicine Across Critical Neurodevelopmental Windows.
CBD neurodevelopmental epilepsy research reveals promising precision medicine approaches targeting critical developmental windows. This review synthesizes evidence on CBD's neuroprotective and antiseizure effects in pediatric epilepsy. Understanding…
Understanding Neurotransmitter Systems in Alzheimer’s Disease
Neurotransmitter systems Alzheimer's disease dysfunction plays a key role in cognitive decline. Multiple systems including cholinergic, glutamatergic, and GABAergic are affected. Understanding these systems helps explain treatment challenges.
Advances in Targeting Amyloid Beta Aggregation and Neuroinflammation in Alzheimer’s
Amyloid beta aggregation Alzheimer's disease is a key pathological mechanism driving cognitive decline. This article reviews advances in targeting amyloid beta aggregation and neuroinflammation. Natural products like curcumin show potential but require…
Reading and Puzzles May Offset Dementia Risk During Sitting
Cognitive engagement dementia prevention is crucial for brain health during sedentary periods. Research shows that activities like reading and puzzles while sitting may help offset dementia risk. This highlights the importance of mental stimulation even…
Therapeutic Potential and Pharmacological Mechanisms of Cannabinoids in Alleviating Chemotherapy-Induced Organ Toxicity
Cannabinoids chemotherapy organ protection research highlights their potential to reduce organ toxicities caused by chemotherapy. These include cardiotoxicity, nephrotoxicity, hepatotoxicity, and neurotoxicity. Understanding pharmacological mechanisms is…
Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity
Cisplatin-induced ototoxicity is a detrimental side effect of chemotherapy leading to hearing loss, for which no treatments are currently available. This study reveals the presence of endocannabinoid signaling pathways in auditory hair cells affected by…